1 Department of Psychiatry, National Institute on Aging, National Institutes of Health, Baltimore.
2 Department of Biomedical Research Center, National Institute on Aging, National Institutes of Health, Baltimore.
3 Department of Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville.
4 Department of Mitchell Woods Pharmaceuticals, Shelton, Connecticut.
5 Department of Epidemiology and Public Health, National Institute on Aging, National Institutes of Health, Baltimore; Department of Division of Translational Toxicology, Pharmacology, National Institute on Aging, National Institutes of Health, Baltimore; Department of Medicine, University of Maryland School of Medicine, National Institute on Aging, National Institutes of Health, Baltimore.
6 Department of Psychiatry, National Institute on Aging, National Institutes of Health, Baltimore; Physiology, National Institute on Aging, National Institutes of Health, Baltimore.
7 Department of Experimental Therapeutics and Pathophysiology Branch, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland.
8 Department of Psychiatry, National Institute on Aging, National Institutes of Health, Baltimore; Department of Division of Translational Toxicology, Pharmacology, National Institute on Aging, National Institutes of Health, Baltimore; Department of Anatomy and Neurobiology, National Institute on Aging, National Institutes of Health, Baltimore. Electronic address: [email protected].